Aptus Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$212K	Buy	+4,368	New	+$212K	﹤0.01%	918
2025 Q1	–	Sell	-6,298	Closed	-$248K	–	1440
2024 Q4	$248K	Buy	+6,298	New	+$248K	﹤0.01%	817
2023 Q3	–	Sell	-4,175	Closed	-$234K	–	900
2023 Q2	$234K	Buy	+4,175	New	+$234K	0.01%	444